As a systematic analysis approach of signaling pathways and associated molecules affected by NMU in breast cancer is still missing we applied the luminal-like, NMUR2-positive SKBR3 gain-of-function model to perform a comprehensive whole genome expression analysis. The gene discussed is NMUR2; the disease is breast carcinoma.